Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Exercise or conversion Chief Financial Officer acquired 4,000 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Exercise or conversion Director acquired 93,124 shares (option exercise)
  5. 4 Other acquisition Director acquired 348,754 shares (other)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale Director sold 48,427 shares at an average $10.07 ($487,498)
  14. 4 Open-market sale Director sold 48,427 shares at an average $10.07 ($487,498)
  15. 4 Open-market sale Director sold 111,498 shares at an average $10.01 ($1,116,290)
  16. 4 Open-market sale Director sold 111,498 shares at an average $10.01 ($1,116,290)
  17. 4 Open-market sale Director sold 59,621 shares at an average $10.80 ($644,048)
  18. 4 Open-market sale Director sold 59,621 shares at an average $10.80 ($644,048)
  19. 4 Open-market sale Director sold 22,463 shares at $10.75 ($241,477)
  20. 4 Open-market sale Director sold 22,463 shares at $10.75 ($241,477)

Page 18 of 20 · 400 filings